Table 2.
Drug resistance proportion to first-line anti-tuberculosis drugs from 329 patients with available DST results versus history of treatment
| DST Results | New patients (n = 187) Frequency (%*) |
Previously treated patients (n = 131) Frequency (%*) |
Unknown patient treatment history (n = 11) Frequency (%*) |
Total (n = 329) Frequency (%*) |
|---|---|---|---|---|
| Susceptible | 149 (45.3%) | 5 (1.5%) | 8 (2.4%) | 251 (76.3%) |
| Mono resistance | ||||
| INH | 14 (4.3) | 19 (5.8%) | ||
| RIF | 10 (3.1%) | 11 (3.3%) | 1 (0.3%) | 22 (6.7%) |
| MDR | 14 (4.3%) | 22 (6.7%) | 2 (0.6%) | 38 (11.6%) |
%* = F× 100/n, DST Drug susceptibility testing, RIF Rifampicin, INH Isoniazid, MDR Multiple drug resistance